NASDAQ · LOGSX
Live Oak Health Sciences Fund
$27.49+$0.41 (+1.51%)
Live Oak Health Sciences Fund’s quoted price sits in the upper half of its reported 52-week range, 0.04% below the high.
Loading market information…
NASDAQ · BFONX · USD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 12:05 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Biondo Focus Fund’s quoted price sits in the upper half of its reported 52-week range, 11.51% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Biondo Focus Fund’s forward annual dividend is $2.59 per share, paid annual. The forward yield is 12.05% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Biondo Focus Fund’s reporting calendar.
THE COMPANY BEHIND THE TICKER
The Biondo Focus Fund principally directs its capital towards a range of long-term holdings. These include equity shares of American corporations, regardless of their market valuation, alongside American Depositary Receipts (ADRs) representing ownership in foreign businesses. The fund also invests in high-grade fixed income instruments, exchange-traded funds (ETFs), and derivative options linked to stocks, ADRs, and ETFs. Furthermore, it possesses the ability to employ financial leverage, potentially through bank loans, up to a maximum of 33% of its total assets, which are defined as the sum of its net assets and any borrowed funds used for investment. It is important to note that this fund operates with a non-diversified investment strategy.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:14 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$27.49+$0.41 (+1.51%)
Live Oak Health Sciences Fund’s quoted price sits in the upper half of its reported 52-week range, 0.04% below the high.
$45.30-$0.64 (-1.39%)
NASDAQ-100 ProFund Service Class’s quoted price sits in the upper half of its reported 52-week range, 6.0% below the high.
$37.92-$0.31 (-0.81%)
Adirondack Small Cap Fund’s quoted price sits in the upper half of its reported 52-week range, 5.08% below the high.
$12.61+$0.06 (+0.48%)
AMF Large Cap Equity Fund’s quoted price sits in the upper half of its reported 52-week range, 1.71% below the high.
$42.58+$0.23 (+0.54%)
ATAC Rotation Fund’s quoted price sits in the upper half of its reported 52-week range, 6.42% below the high.
$13.41-$0.12 (-0.89%)
WesMark Tactical Opportunity Fund’s quoted price sits in the upper half of its reported 52-week range, 3.8% below the high.
$39.89-$0.18 (-0.45%)
Nuveen Large Cap Select Fund Class C’s quoted price sits in the upper half of its reported 52-week range, 4.46% below the high.
$12.16+$0.01 (+0.08%)
T. Rowe Price Target Retirement 2005 Fund’s quoted price sits in the upper half of its reported 52-week range, 1.46% below the high.
